Susquehanna International Group
SLNO

Susquehanna International Group’s Soleno Therapeutics SLNO Stock Holding History

Susquehanna International Group’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.94M Buy
296,900
+42,000
+16% +$1.65M ﹤0.01% 3129
2025
Q4 		$11.8M Sell
254,900
-146,800
-37% -$8.05M ﹤0.01% 2847
2025
Q3 		$27.2M Buy
401,700
+6,800
+2% +$504K ﹤0.01% 1887
2025
Q2 		$33.1M Sell
394,900
-526,400
-57% -$39.4M ﹤0.01% 1511
2025
Q1 		$65.8M Sell
921,300
-207,600
-18% -$10.1M 0.01% 871
2024
Q4 		$50.7M Buy
1,128,900
+769,000
+214% +$39.8M 0.01% 1108
2024
Q3 		$18.2M Buy
359,900
+334,400
+1,311% +$16M ﹤0.01% 1929
2024
Q2 		$1.04M Sell
25,500
-231,300
-90% -$9.8M ﹤0.01% 6492
2024
Q1 		$11M Buy
256,800
+246,400
+2,369% +$11.1M ﹤0.01% 2478
2023
Q4 		$419K Buy
+10,400
New +$296K ﹤0.01% 9091
2023
Q1 		– Sell
-11,100
Closed -$22K – 13424
2022
Q4 		$22K Hold
11,100
– – ﹤0.01% 11735
2022
Q3 		$19K Buy
11,100
+10,360
+1,400% +$25.2K ﹤0.01% 12622
2022
Q2 		$2K Sell
740
-67
-8% -$185 ﹤0.01% 12690
2022
Q1 		$3K Sell
807
-1,340
-62% -$6.94K ﹤0.01% 12852
2021
Q4 		$13K Sell
2,147
-5,120
-70% -$53.7K ﹤0.01% 12898
2021
Q3 		$101K Sell
7,267
-300
-4% -$4.18K ﹤0.01% 12067
2021
Q2 		$129K Buy
7,567
+5,754
+317% +$97.2K ﹤0.01% 11942
2021
Q1 		$34K Buy
1,813
+846
+87% +$27.3K ﹤0.01% 12094
2020
Q4 		$28K Sell
967
-5,066
-84% -$146K ﹤0.01% 10855
2020
Q3 		$227K Sell
6,033
-5,114
-46% -$149K ﹤0.01% 9257
2020
Q2 		$371K Buy
+11,147
New +$483K ﹤0.01% 7964

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

Susquehanna International Group's SLNO Position: Q1 2026 in Review

Susquehanna International Group increased its Soleno Therapeutics (SLNO) stake by 125% in Q1 2026, buying an estimated $12M and bringing the position to 549,877 shares worth $18.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2336.

Susquehanna International Group first reported a position in SLNO in Q1 2017 and has held it in 23 quarters since. The position peaked at $34.6M in Q2 2025. 225 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Susquehanna International Group held 549,877 shares of Soleno Therapeutics worth $18.4M as of Q1 2026.
  • Susquehanna International Group bought 305,519 Soleno Therapeutics shares in Q1 2026, an estimated $12M.
  • Soleno Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2336 holding.
  • Susquehanna International Group first reported a position in Soleno Therapeutics in Q1 2017 and has held it in 23 quarters since.
  • Susquehanna International Group's Soleno Therapeutics position peaked at $34.6M in Q2 2025.
  • 225 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.